An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa
Clinical trial NCT02207816 · COMPLETED
Trial details
- NCT number
- NCT02207816
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-18
- Primary completion
- 2017-01-31
- Enrollment
- 3084
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.